Opportunities and Risks
As a global enterprise with a diversified portfolio, the Bayer Group is exposed to a wide range of internal or external developments or events that could significantly impact the achievement of our financial and nonfinancial objectives.
Bayer regards opportunity and risk management as an integral part of corporate governance. Our risk management process and the opportunities / risks outlined in detail in the Annual Report 2015 (Combined Management Report, Chapter 18.3) are materially unchanged. No risks have been identified that could endanger the Bayer Group’s continued existence. There are also no risks with mutually reinforcing dependencies that could combine to endanger the Group’s continued existence.
Significant developments that have occurred in respect of the legal risks since publication of the Bayer Annual Report 2015 (Note  to the Consolidated Financial Statements) are described in the Notes to the Condensed Consolidated Interim Financial Statements under “Legal Risks.”